《案例分析——差异化聚集让销量倍增（Case analysis differentiation and aggregation make sales doubled）》由会员分享，可在线阅读，更多相关《案例分析——差异化聚集让销量倍增（Case analysis differentiation and aggregation make sales doubled）（14页珍藏版）》请在金锄头文库上搜索。
1、案例分析差异化聚集让销量倍增（Case analysis differentiation and aggregation make sales doubled）Case analysis: differentiation and aggregation make sales doubledSouthern China customer service:Three hundred and forty-two million two hundred thousand three hundred and fifty-fiveNorth China customer service:Five hund
2、red and four million five hundred and sixty-five thousand six hundred and fifteenHubei customer service:Fifty-eight million six hundred and nine thousand four hundred and oneThe latest informationThe medicine marketing topics: basic drug systemSpring fire prevention wellChinese medicine for treating
3、 diabetic skin pruritusThe common pathogenic factors of allergic asthmaBrand OTC sales is how to do itNote the Soybean Milk drinkPopular informationCompound Zedoary Turmeric Oil Suppoaitories is on cervical erosionThe new rural cooperative medical institutions around the use ofThe national health in
4、surance directory queryThe country health department, bureau, biddingHarry Compound Camphor Cream skin beautyIn 2010 the national drug centralized purchasingNews headline newsYour position: Home Information CenterCase analysis: differentiation and aggregation make sales doubledDouble click the auto
5、scroll Publisher: admin release date: 2010-4-9 reading: 79Case analysis: differentiation and aggregation make sales doubledYou have, I have all have, ah, heros song the lyrics like specifically for many small enterprises and write generic drugs: from product, price to marketing mode. But if the ente
6、rprises want to must achieve talent shows itself, you have, I have, I haveCase: Wang JinxueChina has more than 4700 drug manufacturing enterprises, the company annual sales income of 50 million yuan accounted for less than 70% above. Many, small, scattered, low, homogeneous competition will still be
7、 Chinas pharmaceutical industry for a long time the pain. So, for small enterprises in terms of generic drugs, how can the talent shows itself in the fierce competition?The basic competition strategy of the enterprise has 3 kinds: cost leadership strategy, differentiation strategy and focus strategy
8、. The enterprise must choose one from these three kinds of strategy, as its leading strategy. Either the cost control to lower than competitors; or out of the ordinary characteristics in the form of business products and services, so that customers feel that you provide more value; or enterprise ded
9、icated to a particular market segment, a specific product or a specific geographic range.For the small enterprises in terms of generic drugs, what almost no cost advantage, the only viable strategy is the differentiation strategy and focus on the organic combination of strategy, concentration of res
10、ources and capabilities through differentiated competition to seek a breakthrough, at one point: the differentiation focus strategy.Generally speaking, the competition can be divided into six levels, from the price level, quality level, function level, service level, technical level, has been develo
11、ped to the brand level. For small and medium-sized pharmaceutical companies, in addition to already established a certain brand of some enterprises, all in price, technology, quality, function level what no obvious difference, the rest can only fight.In the limited resources and capabilities, not ma
12、ny advantages of small enterprises, must carefully analyze the research on the competitive environment, and fully study the competitors, to carefully assess their own resources and ability to concentrate superior forces, find a breakthrough, blaze a new trail. That is to say, we must find out the st
13、rategies and methods different from others, the only way,The enterprise can get rid of passive situation, one step ahead of others, the first to have the off stage.casesZ pharmaceutical factory has more than 50 years, in the production and sale of OTC based medicine, prescription drug sales rely on
14、investment agency mode, the market basically limited to the province. Due to various reasons, enterprises in brand building, research and technology, market network, team construction has been no big breakthrough, the scale of the enterprise long-term hovering in the three and fifty million yuan. Af
15、ter careful screening, found Z pharmaceutical treatment of stone products T manufacturers less, has a certain product selling point: pure Chinese medicine, good results. At the same time, the region has a certain advantage: Although the development of the hospital is less, but the director of the De
16、partment of several high degree of recognition. In addition, the local high incidence of gallstone disease, but there is no prominent brand. Therefore, the enterprise decided to increase the academic promotion efforts, and priority products T.Experts and enterprises relying on regional professional society, in close coopera
